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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.08.043Objective: We have previously reported a limited but favorable experience with a
novel sutureless technique for surgical management of postoperative pulmonary
vein stenosis occurring after repair of total anomalous pulmonary venous drainage.
Because this technique requires integrity of the retrocardiac space for hemostasis,
extension of the technique to the primary repair of pulmonary vein anomalies
requires evaluation. This analysis reviews our experience with the sutureless tech-
nique in patients with postrepair pulmonary vein stenosis, as well as our extension
of the technique into primary repair of pulmonary vein anomalies.
Methods: Retrospective univariable-multivariable analysis of all pulmonary vein
stenosis procedures and sutureless pulmonary vein procedures over a 20-year period
was performed. Cox proportional hazards modeling was used to identify variables
associated with freedom from reoperation or death.
Results: Sixty patients underwent 73 procedures, with pulmonary vein stenosis present
in 65 procedures. The sutureless technique was used in 40 procedures. Freedom from
reoperation or death at 5 years after the initial procedure was 49%. Unadjusted freedom
from reoperation or death was greater with the sutureless technique for patients with
postrepair pulmonary vein stenosis (P .04). By using multivariable analysis, a higher
pulmonary vein stenosis score was associated with greater risk of reoperation or death.
After adjustment, the sutureless repair was associated with a nonsignificant trend toward
greater freedom from reoperation or death (P .12). Despite the absence of retrocardiac
adhesions, operative mortality was not increased with the sutureless technique (P 
.64). Techniques to control bleeding (intrapleural hilar reapproximation) and improve
exposure (inferior vena cava division) were identified.
Conclusion: The sutureless technique for postrepair pulmonary vein stenosis is
associated with encouraging midterm results. Extension of the indications for the
technique to primary repair appears safe with the development of simple intraop-
erative maneuvers.
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DSurgical relief of pulmonary vein stenosis (PVS)is a difficult clinical problem associated withsignificant risk of recurrent obstruction ordeath, requiring reoperation for stenosis and,in some reports, lung transplantation.1-5 Weand others have previously reported a man-
agement strategy for PVS that is based on the use of a
sutureless technique of pulmonary vein anastomosis.2,4,6-8
Conceptually, the technique is based on the premise that
anastomosis of the left atrium to the pericardium surround-
ing the divided edges of the pulmonary veins (rather than
the edges of the pulmonary veins) will prevent geometric
distortion of the suture line, reduce local turbulence, and
prevent a subsequent spiral of intimal hypertrophy and
progressive local distortion.9,10
The efficacy of the sutureless technique in prevention of
recurrent PVS is not well established. Furthermore, because
the technique relies on the integrity of the retrocardiac
pericardium for hemostasis, the applicability of this tech-
nique to patients without previous cardiac surgery (ie, ab-
sence of pericardial thickening and adhesions) is also not
well established. In the present report our experience with
PVS is reviewed, with the objectives of identifying risk
factors predictive of reoperation or death with various man-
agement strategies and evaluating technical problems asso-
ciated with the sutureless technique.
Methods
At the Hospital for Sick Children in Toronto, 60 patients under-
went operative intervention for PVS between February 1983 and
October 2003. Institutional review board approval was obtained,
and demographic, operative, and postoperative records and echo-
cardiographic data were analyzed. Follow-up was 88% complete
(patient status current to October 2003).
PVS Score
Operative reports and echocardiographic data were reviewed to
grade the severity of PVS in an individual patient, and the reported
degree of stenosis in each pulmonary vein was graded from 0 to 3
(0, no stenosis; 1, mild stenosis; 2, severe stenosis; 3, occluded).
The sum of these scores was defined as the PVS score (possible
range, 0-12).
Statistical Analysis
Data are presented as frequencies, medians with ranges, or means
with SDs. Survival data are represented by using the Kaplan-Meier
method. Stratified survival curves were plotted to explore unad-
justed group differences for variables of interest. A Cox propor-
tional hazards model was fitted with time to death or reoperation as
the dependent variable and stratified by indication categories (de-
scribed below) to allow different baseline hazards for each cate-
gory. Variable selection was backward elimination with bootstrap-
ping. The assumption of proportional hazards was tested by using
an interaction term between time and each variable in the final
model. The final model validation (to assess for overfitting) and
calibration was done by means of bootstrapping. Analyses were
168 The Journal of Thoracic and Cardiovascular Surgery ● Januconducted by using S-plus 6.1 (Insightful Corp) and Statistica
analysis software version 5.5 (StatSoft, Inc).
Results
Patients
The breakdown of the patient population is shown in Figure 1.
The cohort could be categorized into 4 groups (indication
categories) on the basis of the status of the pulmonary veins
(Table 1). Seventeen patients had PVS that developed after
repair of total anomalous pulmonary venous drainage (postre-
pair PVS). Thirty-six patients underwent repair of PVS in the
setting of naive pulmonary veins, which was defined as the
absence of any previous operative procedure specifically ded-
icated to the pulmonary veins. Within this group, 10 patients
had a variety of (nonpulmonary vein) prior cardiac surgical
procedures (postoperative PVS), and 26 patients had PVS in
the absence of any prior cardiac surgery (unoperated PVS).
Seven patients were believed to be at risk for PVS because of
small pulmonary veins and underwent a pulmonary vein en-
larging procedure in association with another operative proce-
dure (small PV). The size of the individual pulmonary veins
adjusted to body surface area for the small pulmonary vein
group was 30 to 46 mm/m2, which is within a range previously
reported to be at high risk for PVS, death, or both.11
Among the 18 patients who died after various operations
on the pulmonary veins, 16 (89%) showed signs of pulmo-
nary venous obstruction before they died.
Procedures
Seventy-three procedures for PVS are shown in Figure 2.
The sutureless repair technique was used in 35 patients as an
initial procedure and in 5 patients as a second procedure.
Catheterization laboratory and operative stenting proce-
dures were often accompanied by multiple balloon dilations
within the pulmonary venous system. Atrial patch proce-
dures (atrial pulmonary venoplasty) were modifications of
the procedure described by Pacifico and colleagues.12
Atretic Pulmonary Veins
The sutureless technique was used in 5 patients with atretic
veins. On immediate postoperative follow-up, all but one
patient had pulmonary vein patency. Three (60%) of the 5
patients, however, died 2 to 4 months after the operation,
and in the remaining 2 patients, only one had patency of the
atretic pulmonary vein.
Incision Versus Excision of the Pulmonary Veins
The decision to excise or incise the stenotic portion of the
pulmonary vein was made on the basis of surgeon discretion
at the time of the operation rather than an institutional
strategy. We tried to excise as much fibrotic tissue as
possible when it subjectively appeared to have proliferative
potential. In the absence of stenosis in the pulmonary veins
themselves (eg, patients with postrepair PVS in the anasto-
ary 2005
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Dmotic site with normal-looking individual veins), we incise
the veins rather than excise them.
Postrepair PVS
Seventeen patients with postrepair PVS underwent 24 pro-
cedures (7 sutureless repairs and 17 cases of conventional
management). When used as the initial procedure for pos-
trepair PVS, the sutureless technique was associated with
unadjusted decreased risk of reoperation or death (univari-
able P .04, Figure 3), with no reoperations or death in the
sutureless group (mean follow-up, 3.1 years).
Sutureless Repair as a Primary Procedure
The sutureless technique was used as a primary procedure
(eg, no previous cardiac operations) in 25 patients with PVS
(n  18) or at increased risk of PVS (n  7). Despite the
absence of retrocardiac adhesions, operative mortality was
not increased compared with that of the patients who had a
sutureless repair as a reoperation (P  .64).
Technical Problems and Maneuvers
Intrapleural hilar reapproximation. When the suture-
less technique was used in patients without previous cardiac
operations, longitudinal division of the pulmonary veins
into the pulmonary hilum was associated with violation of
the thin pleura at the junction between the parietal and
visceral pleura overlying the pulmonary hilum and left atrial
bleeding into the pleural space. This was managed by means
of division of the pericardium and pleura at the level of the
diaphragm from anterior to posterior to the level of the
‘
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Figure 1. Breakdown of patient cohort by indication
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The Journal of Thoracifirmly toward the midline, exposing the anterior aspect of
the pulmonary hilum. The parietal and visceral pleura can
then be approximated with a fine running suture to achieve
hemostasis. This maneuver was used successfully in 4 pa-
tients in whom such bleeding occurred.
Division of the inferior vena cava. Another useful tech-
nique to improve exposure included division of the inferior
vena cava in 12 patients with bilateral PVS. In combination
with division of the left atrium circumferentially around the
pulmonary vein origins, the heart is tethered only by the
superior vena cava, and the great vessel attachments expo-
sure is markedly enhanced.
Statistical Analysis
By using the entire cohort, 1- and 5-year survival after the
initial PVS procedure was 68.1% and 62.3%, respectively,
and freedom from reoperation or death at 1 and 5 years after
the initial procedure was 58% and 49%, respectively.
By using reoperation or death as an end point, there were
60 patients who had 23 events in the final survival model.
No significant violations of the proportional hazards as-
sumptions were identified. Variables included in the model
included right atrial isomerism, the extent of PVS (PVS
score), age, indication category (as a stratification variable),
and procedure type. The PVS score was the only indepen-
dent predictor of reoperation or death, with a hazard ratio of
12.9 for a 5-point change from a score of 2 to a score of 7
(range, 0-10; median, 4; P  .0001; Figure 4). After adjust-
ing for PVS score and stratifying by indication category,
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Dfrom death or reoperation with the sutureless technique
(hazard ratio, 0.47; P  .12). When controlling for PVS
score, bilateral stenosis was not a significant risk factor for
reoperation or death.
Because of heterogeneity and the small number of pa-
tients, we failed to demonstrate robust model validity and
calibration by bootstrapping. Therefore the results of this
TABLE 1. Profiles of patient groups
Group
PR-PVS (n  17) Median age at TAPVD repair:
Median age at PR-PVS repair
Sex (M/F):
Types of TAPVD:
Functional single ventricle:
Associated anomalies:
PO-PVS (n  10) Median age at initial cardiac
Median age at PO-PVS repair
Median interval:
Sex (M/F):
Original diagnosis:
Initial operation:
Unoperated PVS (n  26) Median age at PVS repair:
Sex (M/F):
Associated anomalies:
Small PV (n  7) Diagnosis:
Truncus arteriosus, TAPVD
CoA, ASD, TAPVD
HLHS
RAI, AVSD, PS, TAPVD
RAI, AVSD, PS, TAPVD
RAI, AVSD, PS, TAPVD
RAI, AVSD, PS, TAPVD
TAPVD, Total anomalous pulmonary venous drainage; PR-PVS, postrepai
pulmonary vein stenosis; HLHS, hypoplastic left heart syndrome; D-TGA, dex
septal defect; AVSD, atrioventricular septal defect; PDA, patent ductus
pulmonary stenosis; LMBT, left modified Blalock-Taussig shunt; BCPS, bidmodel might experience overfitting and should not be inter-
170 The Journal of Thoracic and Cardiovascular Surgery ● Janupreted in the context of hypothesis testing but rather hy-
pothesis generation.
Discussion
PVS is a challenging problem because of the recurrent and
often inexorable progression of the disease. The sutureless
technique has been used in many centers for postrepair PVS,
3 d
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Dvious reports,2,8 the indications for this technique in our
institution have evolved beyond the original indication of
postrepair PVS and now extend to patients without previous
cardiac operations and patients at risk for PVS because of
the presence of small pulmonary veins.11 In the present
study, when controlling for other important variables, sup-
port for the sutureless technique is encouraging but not
definitive. Nevertheless, the technique has a favorable
safety profile in the postoperative and nonoperated medias-
tinum. In addition, technical problems, such as limited ex-
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1st PV
procedure
Patch PVP (n=10)
Death: 5/10
SR (n=5)
Death:1/5
2nd PV
procedure
3rd PV
procedure
3
2
1
Figure 2. Breakdown of procedures performe
0
0.0
0.2
0.4
0.6
0.8
1.0
C
u
m
u
la
ti
v
e
 p
ro
p
o
rt
io
n
 f
re
e
 o
f 
re
o
p
e
ra
ti
o
n
 o
r 
d
e
a
th
Figure 3. Unadjusted freedom from reoperation or dea
technique versus other surgical techniques. Vertical mposure and bleeding, can be controlled with simple maneu-
The Journal of Thoracivers (eg, division of the inferior vena cava and intrapleural
hilar reapproximation).
The finding that the PVS score was the only statistically
significant predictor of reoperation or death is interesting in
that it might more accurately reflect the pulmonary venous
pathology in comparison with our previous reports with a
unilateral-bilateral stenosis classification scheme.2 The PVS
score used in the present study ignores the presence of
anastomotic stenosis, which might reflect surgical imperfec-
tion at the anastomosis rather than diffuse pulmonary ve-
cedures
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th fonous pathology. Instead, the PVS score assesses the indi-
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Dvidual pulmonary veins and might better reflect pulmonary
venous pathology. This rationale is very similar to the use of
the pulmonary vein diameter sum as a predictor of recurrent
PVS, as reported by Jenkins and associates.11
Because of the small sample size and the diversity of
indication categories and operative techniques, the ability to
draw conclusions is limited. On the basis of the presented
data, the sample size needed to test the hypothesis that the
sutureless technique reduces the risk of reoperation or death
by 50% across the range of indication categories analyzed in
the present study is approximately 150 patients in the setting
of a randomized trial. In the setting of a retrospective study,
however, where adjustment for baseline differences is re-
quired, a larger sample size would be required. Conse-
quently, our ability to prove that the sutureless technique is
advantageous might require more than doubling the size of
our patient cohort, which will require 10 years at present
rates of patient accrual.
An alternative strategy would be to limit analysis to the
group of patients with the greatest risk of recurrent PVS and
thereby increase the likelihood of detecting a benefit with
the sutureless technique (if present). In subgroup analysis
the postrepair PVS group seemed to derive the most benefit
from sutureless repair, a finding that is consistent with the
findings of others and might reflect the high rate of reste-
nosis (and benefit) in this group of patients.4-6 Conse-
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Figure 4. Freedom from reoperation or death stratified
uncensored events.quently, registry data from multiple sites selecting a high-
172 The Journal of Thoracic and Cardiovascular Surgery ● Janurisk population (eg, postrepair PVS) and allowing analysis
of a large patient population is likely to be an expedient
approach to validation of the sutureless technique. Data
derived from the present study suggest that registry data
should be adjusted for the extent of PVS (eg, PVS score).
The rationale for extending the use of the sutureless
technique for the patients with small pulmonary veins be-
lieved to be at risk for future stenosis is based on a reason-
able safety profile and reports that small pulmonary veins
are important risk factors for later development of PVS after
conventional total anomalous pulmonary venous drainage
repair.11,13,14 In this regard we have recently changed our
institutional strategy for the management of right atrial
isomerism–total anomalous pulmonary venous drainage in
patients undergoing single-ventricle palliation to primary
sutureless repair. To demonstrate that a prophylactic pri-
mary sutureless repair for this subset of patients is effica-
cious will also require a very large patient cohort and is
beyond the scope of the present study. Again, registry data
might be the most expedient approach to evaluation of this
strategy.
An important limitation of the study is that the PVS score
is subjective in the grading of PVS and relies on retrospec-
tive inspection of echocardiographic and operative notes. In
our current practice we rely heavily on high-resolution
echocardiographic and magnetic resonance imaging data to
10 15
 (yrs)
 PVS score: 0-3
 PVS score: 4-7
 PVS score: 8-12
p=0.00065
PVS score. Vertical marks, censored events; circles,Time
byallow more objective prospective grading of pulmonary
ary 2005
Yun et al Surgery for Congenital Heart Disease
CH
Dvein pathology. Other weaknesses of the PVS score include
the unavoidable loss of data with an ordinal variable (in
contrast to a continuous variable), the lack of differentiation
between localized and diffuse hypoplasia, and the lack of
consideration of bilateral disease (eg, unilateral severe dis-
ease with a score of 4 is considered identical to bilateral
mild disease with a score of 4).
Another important limitation of the present study is the
small sample size, which leads to the use of a combined end
point (reoperation or death) in the statistical analysis. Al-
though this method improves the statistical power of the
study, the outcomes cannot be considered equivalent.
As our patient population grows, we anticipate develop-
ment of more robust statistical models to identify important
predictors of success and failure in the management of this
complex group of patients. With identification of these
predictors, prophylactic strategies can be more expediently
tested in newly identified high-risk populations, and man-
agement strategies can be modified for individual patients.
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Discussion
Dr Francois Lacour-Gayet (Denver, Colo). Dr Tai-Jin Yun, I
congratulate you for this excellent presentation that reports one of
the largest series of PVS repair ever published.
As you said in your article, pulmonary vein surgery is danger-
ous. I will add that it can be frustrating.
Your study had very interesting information. You identify a
new type of PVS occurring after nonpulmonary vein surgery. We
have also seen this concerning group of patients.
You confirmed that the sutureless repair can be extended safely
to native PVS conducted into the adhesion-free pericardial cavity.
Your pulmonary venous score in 4 grades described very well the
large spectrum of the disease. In this regard we have recently seen
very severe forms with total pulmonary venous obstruction of one
lung in which the patency of the pulmonary venous trunk could
only be documented on magnetic resonance imaging.
Your article seems to recognize also some benefits to other
techniques. My personal experience has been very much in favor
of the sutureless repair. Since April 1995, when I first used this
technique, I have not used another method. I thus far have not had
any hemorrhagic complications and treat the left pulmonary vein
from inside the left atrium. I resect totally the pulmonary venous
lesion.
I would like to ask you the 3 following questions.
First, when dealing with a stenosis, I understand that you prefer
to leave in place the lesion and open it longitudinally more than
totally resect it. Could you comment on this?
Second, you have identified a new type of acquired PVS after
nonpulmonary vein cardiac surgery. Could you comment on the
cause of this pathology, which I have also observed? Could it be
that the intraoperative traumatic process is a cause?
Finally, when there is a total pulmonary venous obstruction
with a blind lung that corresponds, I understand, to your grade 3,
do you consider that it is too late to do anything, or will you still
go on and try to fix the stenosis to recover the lung?
Dr Yun. Thank you, Dr Lacour-Gayet. Regarding your first
question of whether we excise or incise the stenotic vein, the
decision is made on the basis of the operative findings rather than
institutional strategy. We try to excise as much tissue as possible
when it looks unhealthy and might have some proliferative poten-
tial. If the stenosis is too close to the hilar area, however, excessive
excision is dangerous and might lead to intractable intrapleural
bleeding.
Regarding your second question, we have 10 patients who had
PVS after various cardiac operations. We classified those patients
as the postoperative group rather than the postrepair group because
these patients did not have congenital abnormalities of the pulmo-
nary veins. These patients had cardiac operations that were not
specifically dedicated to the pulmonary veins, but this does not
necessarily mean that the primary operation has nothing to do with
the development of PVS. For example, one patient had ventricular
c and Cardiovascular Surgery ● Volume 129, Number 1 173
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Dseptal defect repair with a left atrial vent in the right upper
pulmonary vein and had right upper PVS. We did a sutureless
repair for right-sided pulmonary veins. During follow-up, the
patient had recurrent PVS in the left side, which necessitated a
second sutureless repair. The first PVS was presumably acquired
disease, but the second PVS is of unclear cause, although it
suggests an intrinsic abnormality in the pulmonary vein response
to contralateral PVS.
Regarding your third question, I would say the indication for
operation for the individual pulmonary vein might be different
from the indication for operation for the patient. If you have a
patient who has one atretic vein and 2 stenotic veins, there should
not be any hesitation to open up the atretic pulmonary vein. But if
you have a patient who has one atretic vein with mild symptoms
and mildly increased right ventricular pressure, that is going to be
a tough decision regarding the indication for operation. In our
series we have some patients who had atretic pulmonary veins that
were opened up. The end point of our observation was, however,
reoperation or death and not the obstruction of the pulmonary
veins we worked on, and we did not analyze the fate of the
pulmonary vein after the operation.
Dr Thomas L. Spray (Philadelphia, Pa). One of the real issues
here is the pulmonary artery pressure or right ventricular pressure
before you do this procedure. If the mean pulmonary vein score is
somewhere in the neighborhood of 6 or 7, that means that poten-
tially 2 of the veins are open and 2 are closed. That might or might
not be associated with pulmonary hypertension. One of the real
concerns in distinguishing between what has been considered
congenital PVS or veno-occlusive disease and either unilateral
PVS, which can be congenital, or postrepair vein stenosis is
determining the pulmonary artery pressure. If you have 1 or 2
veins that are unaffected and yet your pulmonary artery pressure is
systemic or higher, that portends a worse overall long-term out-
come, no matter what you do with the pulmonary vein repair.
Therefore the question I have to ask you is as follows: What
were the right ventricular pressures in these patients in general, and
then how did they respond to the repair, whether the vein stayed
open or not?
Dr Yun. We have all echocardiographic data for our patients,
but we did not include right ventricular pressure or gradient in the
stenotic portion of the pulmonary vein in our analysis because of
the heterogeneity of the patients. Right ventricular pressure might
be useful for the risk factor analysis or outcome interpretation in
some patient groups, such as postrepair PVS or congenital PVS
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not be applied to single-ventricle physiology or some patients who
have biventricular physiology with an intracardiac shunt. In pa-
tients who had sutureless repair for postrepair PVS, right ventric-
ular pressure was normalized after the operation and has been kept
normal in all patients. In the congenital PVS group we have 18
patients with 6 reoperation deaths. In the remaining 12 patients,
about one third of patients have a right ventricular/left ventricular
pressure ratio of greater than 0.5.
Dr Spray. But presumably the ones who died might have had
the higher pulmonary artery pressures that did not respond to your
treatment. That is one implication of the reasonably high mortality.
Dr Yun. Yes.
Dr Carl L. Backer (Chicago, Ill). I have a quick technical
question. In this operation the suture line comes very close to both
the left and right phrenic nerves. Do you have data about whether
there was phrenic nerve injury in any of these patients? Do you
have any tips to help avoid the phrenic nerve, which, again, is very
close to that suture line?
Dr Yun. We tried to keep our suture line far posterior to the
phrenic nerve. If we do the sutureless repair as a primary operation
without any previous operation, we can see the course of the
phrenic nerve very easily from inside because the pericardium is
semitransparent. Furthermore, we open up the pleura on both sides
when we do bilateral sutureless repair for 2 reasons: first, to check
the course of the phrenic nerve from outside as well, and second,
to check whether there is any intrapleural bleeding after comple-
tion of the procedure. If we do the sutureless repair in patients who
have previous cardiac operations, then we have to check the course
of the phrenic nerve from outside before we place a suture on the
pericardium.
Dr Felix Haas (Muenchen, Germany). This is, indeed, a very
interesting and useful technique to relieve PVS.
In my personal experience I believe that the right side is much
easier to do than the left side. Did you find any differences between
the left and right sides in terms of outcome or in terms of reste-
nosis?
Dr Yun. Well, yes, we had some difficulties when we did the
left-side sutureless repair. But recently we began to divide the
inferior vena cava and lift up the heart toward the right side. After
this technical modification, we did not have any difficulties in
doing the left side. Divisions of the inferior vena cava is a very
useful technique for bilateral sutureless repair as well.
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